Skip to search boxSkip to navigationSkip to main content

ATP-depleting carbohydrates prevent tumor necrosis factor receptor 1-dependent apoptotic and necrotic liver injury in mice

  • Markus Latta
    ,
  • Gerald Künstle
    ,
  • ,
  • Hannes Hentze(corresponding author)
    ,
  • Albrecht Wendel
*Corresponding author for this work
  • LEO Pharma AS
    ,
  • University of Konstanz
    ,
  • Aurigon Life Science GmbH
    ,
  • IMC University of Applied Sciences Krems
    ,
  • ES Cell International
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

We demonstrated previously that depletion of hepatic ATP by endogenous metabolic shunting of phosphate after fructose treatment renders hepatocytes resistant to tumor necrosis factor (TNF)-induced apoptosis. We here address the question whether this principle extends to TNF receptor 1-mediated caspase-independent apoptotic and to necrotic liver injury. As in the apoptotic model of galactosamine/lipopolysaccharide (LPS)-induced liver damage, the necrotic hepatotoxicity initiated by sole high-dose LPS treatment was abrogated after depletion of hepatic ATP. Although systemic TNF and interferon- γlevels were suppressed, animals still were protected when ATP depletion was initiated after the peak of proinflammatory cytokines upon LPS injection, showing that fructose-induced ATP depletion affects both cytokine release and action. In T cell-dependent necrotic hepatotoxicity elicited by concanavalin A or galactosamine + staphylococcal enterotoxin B, ATP depletion prevented liver injury as well, but here without modulating cytokine release. By attenuating caspase-8 activation, ATP depletion of hepatocytes in vitro impaired TNF receptor signaling by the death-inducing signaling complex, whereas receptor internalization and nuclear factor-κB activation upon TNF stimulation were unaffected. These findings demonstrate that sufficient target cell ATP levels are required for the execution of both apoptotic and necrotic TNF-receptor 1-mediated liver cell death.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 875-883 (9 pages)

Journal (Volume, Issue Number)

Journal of Pharmacology and Experimental Therapeutics (Volume 321, Issue 3)

Publication milestones

  • Published - 06/2007

Publication status

Published - 06/2007

ISSN

0022-3565

Publication IDs

  • Scopus: 34248513282
  • PubMed: 17369282

Publication metrics

Metrics

SciVal
citations
7
SciVal
FWCI
0.34
SciVal
Author count
5
SciVal
Paper percentile
55
Scopus
citations
Fractional count
1
Fractional count
0.20
Fractional count
4
Fractional count
0.80
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
22
Citation count
9